Skip NavigationSkip to Content
Return Return to Search Results

Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27

  1. Author:
    Fakruddin, J. M.
    Lempicki, R. A.
    Gorelick, R. J.
    Yang, J.
    Adelsberger, J. W.
    Garcia-Pineres, A. J.
    Pinto, L. A.
    Lanes, H. C.
    Imamichi, T.

  2. Author Address

    NCI, SAIC Frederick Inc, Lab Human Retrovirol, CSP, Frederick, MD 21702 USA. NCI, SAIC Frederick Inc, Lab Immunopathogenesis & Bioinformat, CSP, Frederick, MD 21702 USA. NCI, SAIC Frederick Inc, AIDS Vaccine Program, Retroviral Mutagenesis Sect, Frederick, MD 21702 USA. NCI, SAIC Frederick Inc, AIDS Monitoring Lab, CSP, Frederick, MD 21702 USA. NCI, SAIC Frederick Inc, HPV Monitoring Lab, CSP, Frederick, MD 21702 USA. NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA.;Imamichi, T, NCI, SAIC Frederick Inc, Lab Human Retrovirol, CSP, Bldg 550,Rm 126,Sultan Dr,POB B, Frederick, MD 21702 USA.;timamichi@mail.nih.gov
    1. Year: 2007
    2. Date: Mar
  2. Journal: Blood
    1. 109
    2. 5
    3. Pages: 1841-1849
  4. Type of Article: Article
  5. ISSN: 0006-4971
  1. Abstract:

    Human papilloma virus (HPV)-like particles (VLPs) have been used as a vaccine to prevent HPV infection. Recent studies demonstrate that VLPs bind to dendritic cells and induce the expression of antiviral cytokines such as interferon-alpha (IFN-alpha), interleukin-10 (IL-10) and IFN-gamma. In the present study, we evaluated the effect of VLPs on HIV-1 replication in peripheral blood mononuclear cells (PBMCs), CD4(+) T cells, and macrophages. Here, we show that VLPs suppress the replication of both X4 and R5 HIV-1 without affecting the expression of CD4, CXCR4, and CCR5. Soluble factor(s) released by PBMCs and macrophages on VLPs treatment inhibited HIV-1 replication. To determine the inhibitory factors, DNA microarray analysis was performed using VLP-treated PBMCs and macrophages. VLPs induced the genes associated with IFN induction, immune responses, and antiviral responses, among with the recently described cytokine IL-27. Subsequently, IL-27 was found to be a potent inhibitor of HIV-1 replication in PBMCs, CD4(+) T cells, and macrophages. Taken together, our studies identify a novel role of IL-27 in restricting HIV-1 replication and suggest that further examination of the inhibitory property of IL-27 may pave the way for a novel therapy for HIV-1 infection.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1182/blood-2006-02-001578
  3. View record in Web of Science®
  4. WOS: 000244641100016

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel